{"id":"https://openalex.org/W2585865211","doi":"https://doi.org/10.2174/1567205014666170117141330","title":"Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer\u2019s Disease: Results from a Double-Blind, Placebo-Controlled Trial","display_name":"Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer\u2019s Disease: Results from a Double-Blind, Placebo-Controlled Trial","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-16","ids":{"openalex":"https://openalex.org/W2585865211","doi":"https://doi.org/10.2174/1567205014666170117141330","mag":"2585865211","pmid":"https://pubmed.ncbi.nlm.nih.gov/28124585","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5706445"},"language":"en","primary_location":{"id":"doi:10.2174/1567205014666170117141330","doi":"https://doi.org/10.2174/1567205014666170117141330","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1567205014666170117141330","pdf_url":null,"source":{"id":"https://openalex.org/S188438558","display_name":"Current Alzheimer Research","issn_l":"1567-2050","issn":["1567-2050","1875-5828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Alzheimer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2585865211"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5706445/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012941668","display_name":"Boris Decourt","orcid":"https://orcid.org/0000-0001-7637-5034","observed_orcids":["https://orcid.org/0000-0001-7637-5034"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Boris Decourt","raw_affiliation_strings":["the Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074216145","display_name":"Denise Drumm-Gurnee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Denise Drumm-Gurnee","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077538089","display_name":"Jeffrey R. Wilson","orcid":"https://orcid.org/0000-0001-9072-1714","observed_orcids":["https://orcid.org/0000-0001-9072-1714"]},"institutions":[{"id":"https://openalex.org/I55732556","display_name":"Arizona State University","ror":"https://ror.org/03efmqc40","country_code":"US","type":"education","lineage":["https://openalex.org/I55732556"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Wilson","raw_affiliation_strings":["Department of Mathematics, Arizona State University, Tempe AZ,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Mathematics, Arizona State University, Tempe AZ,, United States","institution_ids":["https://openalex.org/I55732556"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041058968","display_name":"Sandra A. Jacobson","orcid":"https://orcid.org/0000-0001-6839-6900","observed_orcids":["https://orcid.org/0000-0001-6839-6900"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Jacobson","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060052301","display_name":"Christine M. Belden","orcid":"https://orcid.org/0000-0001-9833-7100","observed_orcids":["https://orcid.org/0000-0001-9833-7100"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christine Belden","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032962923","display_name":"Sherye A. Sirrel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sherye Sirrel","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040780038","display_name":"Michael H. Malek\u2010Ahmadi","orcid":"https://orcid.org/0000-0001-9901-3650","observed_orcids":["https://orcid.org/0000-0001-9901-3650"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Ahmadi","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067565944","display_name":"Holly A. Shill","orcid":"https://orcid.org/0000-0003-1284-5038","observed_orcids":["https://orcid.org/0000-0003-1284-5038"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Holly Shill","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102714081","display_name":"Jessica L. Powell","orcid":"https://orcid.org/0000-0001-5120-7675","observed_orcids":["https://orcid.org/0000-0001-5120-7675"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jessica Powell","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086575735","display_name":"Aaron W. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron Walker","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113512910","display_name":"Amanda Gonzales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amanda Gonzales","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028096919","display_name":"MiMi P. Macias","orcid":"https://orcid.org/0009-0004-6148-3488","observed_orcids":["https://orcid.org/0009-0004-6148-3488"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mimi Macias","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088718520","display_name":"Marwan Noel Sabbagh","orcid":"https://orcid.org/0000-0001-8139-3309","observed_orcids":["https://orcid.org/0000-0001-8139-3309"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marwan N. Sabbagh","raw_affiliation_strings":["Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, 240 West Thomas, Suite 301, Phoenix, AZ 85013,, United States","institution_ids":["https://openalex.org/I1324766304"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0098,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.92278442,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"14","issue":"4","first_page":"403","last_page":"411"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/bace1-inhibition","display_name":"BACE1 inhibition","score":0.9100000262260437},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7850000262260437},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.921999990940094},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.9649999737739563},{"id":"https://openalex.org/keywords/anti-amyloid-therapy","display_name":"anti-amyloid therapy","score":0.5189999938011169},{"id":"https://openalex.org/keywords/app23-mice","display_name":"APP23 mice","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8928550481796265},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.8565436005592346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7210190296173096},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.665173351764679},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6419786214828491},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.610986053943634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5042866468429565},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4766945540904999},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46053624153137207},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45156338810920715},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.43431204557418823},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2747690677642822},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.20764386653900146},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07022547721862793},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004522","descriptor_name":"Educational Status","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/1567205014666170117141330","doi":"https://doi.org/10.2174/1567205014666170117141330","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1567205014666170117141330","pdf_url":null,"source":{"id":"https://openalex.org/S188438558","display_name":"Current Alzheimer Research","issn_l":"1567-2050","issn":["1567-2050","1875-5828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Alzheimer Research","raw_type":"journal-article"},{"id":"pmid:28124585","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28124585","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Alzheimer research","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:5706445","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5706445/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Alzheimer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5706445","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5706445/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Alzheimer Res","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G704822541","display_name":"Arizona Alzheimer's Disease Core Center","funder_award_id":"P30AG019610","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7734810636","display_name":"Pre-clinical testing of lenalidomide as pleiotropic therapeutics of Alzheimer's disease","funder_award_id":"K01AG047279","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7831551873","display_name":"Study on Thalidomide as BACE1 inhibitor in Alzhiemer's disease","funder_award_id":"R01AG034155","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W82102401","https://openalex.org/W196680064","https://openalex.org/W1973907174","https://openalex.org/W1974873541","https://openalex.org/W1986830236","https://openalex.org/W1992474532","https://openalex.org/W1993179378","https://openalex.org/W1996985281","https://openalex.org/W2001032146","https://openalex.org/W2032074003","https://openalex.org/W2033067082","https://openalex.org/W2039373683","https://openalex.org/W2047418563","https://openalex.org/W2071260493","https://openalex.org/W2080274663","https://openalex.org/W2091022795","https://openalex.org/W2093426751","https://openalex.org/W2095367777","https://openalex.org/W2116632271","https://openalex.org/W2128831073","https://openalex.org/W2129497119","https://openalex.org/W2131701266","https://openalex.org/W2148494144","https://openalex.org/W2169822818","https://openalex.org/W2295658886","https://openalex.org/W2969438869"],"related_works":["https://openalex.org/W2041480891","https://openalex.org/W2033881365","https://openalex.org/W2106120339","https://openalex.org/W1718995988","https://openalex.org/W2163049727","https://openalex.org/W2158160931","https://openalex.org/W2135780456","https://openalex.org/W2077997327","https://openalex.org/W4406223924","https://openalex.org/W4403398542"],"abstract_inverted_index":{"INTRODUCTION:":[0],"To":[1],"date":[2],"there":[3],"is":[4],"no":[5,234],"cure":[6],"for":[7,74,257],"Alzheimer's":[8],"disease":[9],"(AD).":[10],"After":[11],"amyloid":[12,85],"beta":[13],"immunotherapies":[14],"have":[15,151,254,272],"failed":[16,282],"to":[17,60,68,127,197,262,268,271,283],"meet":[18],"primary":[19,131],"endpoints":[20],"of":[21,30,72,114,120,143,148,155,161,204,221,226,245,277],"slowing":[22],"cognitive":[23,92,137,231],"decline":[24,93],"in":[25,43,90,94,123],"AD":[26,252],"subjects,":[27],"the":[28,31,48,70,162,189,202,205,212,217,237,243,246],"inhibition":[29],"beta-secretase":[32],"BACE1":[33],"appears":[34],"as":[35],"a":[36,102,117,141,264,285],"promising":[37],"therapeutic":[38,219,265],"approach.":[39],"Pre-clinical":[40],"data":[41,232],"obtained":[42],"APP23":[44],"mice":[45],"suggested":[46],"that":[47,78],"anti-cancer":[49],"drug":[50],"thalidomide":[51,73,79,115,224],"decreases":[52],"brainBACE1":[53],"and":[54,136,182,239,259],"A\u03b2":[55],"levels.":[56],"This":[57,100,249],"prompted":[58],"us":[59],"develop":[61],"an":[62],"NIH-supported":[63],"Phase":[64],"IIa":[65],"clinical":[66],"trial":[67],"test":[69],"potential":[71],"AD.":[75,129],"We":[76],"hypothesized":[77],"can":[80],"decrease":[81],"or":[82],"stabilize":[83],"brain":[84],"deposits,":[86],"which":[87],"would":[88],"result":[89],"slower":[91],"drug-":[95],"versus":[96],"placebo-treated":[97],"subjects.":[98],"METHODS:":[99],"was":[101,166,172,179,186],"24-week,":[103],"randomized,":[104],"double-blind,":[105],"placebo-controlled,":[106],"parallel":[107],"group":[108],"study":[109,213,250,281],"with":[110,116,125],"escalating":[111],"dose":[112,119,220,266],"regimen":[113],"target":[118],"400mg":[121],"daily":[122],"patients":[124,253],"mild":[126],"moderate":[128],"The":[130,230],"outcome":[132],"measures":[133],"were":[134,157],"tolerability":[135,256],"performance":[138],"assessed":[139],"by":[140],"battery":[142],"tests.":[144],"RESULTS:":[145],"A":[146],"total":[147],"185":[149],"subjects":[150],"been":[152],"pre-screened,":[153],"out":[154],"which25":[156],"randomized.":[158],"Mean":[159],"age":[160],"sample":[163],"at":[164,242],"baseline":[165],"73.64":[167],"(\u00b17.20)":[168],"years;":[169,175],"mean":[170,176,183],"education":[171],"14.24":[173],"(\u00b12.3)":[174],"MMSE":[177],"score":[178,185],"21.00":[180],"(\u00b15.32);":[181],"GDS":[184],"2.76":[187],"(\u00b12.28).Among":[188],"25":[190],"participants,":[191],"14":[192],"(56%)":[193],"terminated":[194],"early":[195],"due":[196],"adverse":[198,228],"events,":[199],"dramatically":[200],"decreasing":[201],"power":[203],"study.":[206],"In":[207],"addition,":[208],"those":[209],"who":[210],"completed":[211],"(44%)":[214],"never":[215],"reached":[216],"estimated":[218],"400":[222],"mg/day":[223],"because":[225],"reported":[227],"events.":[229],"showed":[233],"difference":[235],"between":[236],"treated":[238],"placebo":[240],"groups":[241],"end":[244],"trial.":[247],"CONCLUSION:":[248],"demonstrates":[251],"poor":[255,278],"thalidomide,":[258],"are":[260],"unable":[261],"reach":[263],"felt":[267],"be":[269],"sufficient":[270],"effects":[273],"on":[274,288],"BACE1.":[275],"Because":[276],"tolerability,":[279],"this":[280],"demonstrate":[284],"beneficial":[286],"effect":[287],"cognition.":[289]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2585865211","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-02-10T00:00:00"}
